2024-03-29T00:19:02Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_41C980E74B25
2024-03-23T02:16:49Z
serval:BIB_41C980E74B25
Adverse effects of incretin therapy for type 2 diabetes
10.1001/jama.298.15.1759-b
17940229
000250187300016
E.
Grouzmann
author
M.
Monod
author
B. N.
Landis
author
J. S.
Lacroix
author
article
letter
2007-10
JAMA
1538-3598
journal
298
15
1759-60; author reply 1760
Antigens, CD26/*antagonists & inhibitors
Diabetes Mellitus, Type 2/*drug therapy
Glucagon-Like Peptide 1/analogs & derivatives/therapeutic use
Humans
Hypoglycemic Agents/*adverse effects/therapeutic use
Inflammation
Nasopharyngitis
Substance P
Comment
Letter --- Old month value: Oct 17
60_published